Myra O. McClure

9.9k citations

172 papers · 6.8k indexed · 1 hit paper · h-index 44

Virology top 0.2%
Infectious Diseases top 0.5%
Epidemiology top 1%
Molecular Biology top 5%
Genetics top 1%

Co-authors: Robin A. Weiss Jonathan Weber Mark Marsh Paul D. Bieniasz Otto Erlwein Massimo Pizzato Yasuhiro Takeuchi Bryan R. Cullen
Topics: HIV Research and Treatment (68 papers)HIV/AIDS drug development and treatment (41 papers)HIV/AIDS Research and Interventions (34 papers)
Cited by: Virology Infectious Diseases Microbiology
Journals: Nature Proceedings of the National Academy of Sciences The Lancet
Partner nations: United Kingdom United States Germany

In The Last Decade

Myra O. McClure

170 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

1983 412 citations Myra O. McClure et al. profile →

Peers

Countries citing papers authored by Myra O. McClure

Since Specialization

Citations

This map shows the geographic impact of Myra O. McClure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myra O. McClure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myra O. McClure more than expected).

Fields of papers citing papers by Myra O. McClure

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myra O. McClure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myra O. McClure. The network helps show where Myra O. McClure may publish in the future.

Co-authorship network of co-authors of Myra O. McClure

This figure shows the co-authorship network connecting the top 25 collaborators of Myra O. McClure. A scholar is included among the top collaborators of Myra O. McClure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myra O. McClure. Myra O. McClure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: Antibody dynamics and linkage to severity of COVID-19 in hospital inpatients 2022 ·Journal of Infection ·Samreen Ijaz,(unknown),(unknown),Eleanor Parker,(unknown),Elen Vink,Myra O. McClure,Justin Shute,(unknown),Nicola Cook,Peter Cherepanov,Lance Turtle,William A. Paxton,Georgios Pollakis,Antonia Ho,Peter Openshaw,J. Kenneth Baillie,Malcolm G. Semple,Richard S. Tedder	2
2	Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control 2021 ·Journal of Virological Methods ·Aileen Rowan,Philippa C. May,Anjna Badhan,Carolina Herrera,(unknown),(unknown),Michael A. Crone,Marko Storch,Jeremy A. Garson,Myra O. McClure,Paul S. Freemont,Pinglawathee Madona,Paul Randell,Graham P. Taylor	8
3	Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia 2020 ·Blood ·Simone Claudiani,Carolina Rosadas,Myra O. McClure,Maryam Khan,Richard S. Tedder,Andrew J. Innes,Dragana Milojković,Jane F. Apperley	8
4	Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections 2018 ·PLoS ONE ·Paula Blomquist,(unknown),Gillian Wills,(unknown),A. E. Ades,Daphne Kounali,J Kevin Dunbar,Myra O. McClure,Kate Soldan,Sarah C Woodhall,Paddy Horner	13
5	Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters 2013 ·Retrovirology ·Astrid Gall,Steve Kaye,Stéphane Hué,David Bonsall,Richard Rance,Gregory J. Baillie,Sarah Fidler,Jonathan Weber,Myra O. McClure,Paul Kellam,(unknown)	17
6	Alterations in Cerebrospinal Fluid Chemokines Are Associated With Maraviroc Exposure and In Vivo Metabolites Measurable by Magnetic Resonance Spectroscopy 2012 ·HIV Clinical Trials ·Jaime H. Vera,Lucy Garvey,Joanna Allsop,Steve Kaye,Myra O. McClure,David Back,Simon D. Taylor‐Robinson,Alan Winston	12
7	Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers 2011 ·Journal of Antimicrobial Chemotherapy ·(unknown),Lucy Garvey,(unknown),H Lamba,(unknown),(unknown),(unknown),Myra O. McClure,Laura Dickinson,Antonio D’Avolio,David Back,Alan Winston	7
8	Getting the measure of syphilis: qPCR to better understand early infection 2011 ·Sexually Transmitted Infections ·Craig Tipple,(unknown),S. Hill,J. Daniel,David Goldmeier,Myra O. McClure,G. P. Taylor	43
9	HIV-1 does not significantly influence Chlamydia trachomatis serovar L2 replication in vitro 2011 ·Microbes and Infection ·Andrew J. Broadbent,Paddy Horner,Gillian Wills,(unknown),Raffaella Carzaniga,Myra O. McClure	2
10	Protective HLA class I alleles are associated with reduced immune activation and fibrinolysis in individuals with primary HIV infection 2010 ·UCL Discovery (University College London) ·Elizabeth Hamlyn,(unknown),John Frater,(unknown),Ahmed Babiker,Myra O. McClure,Sarah Fidler	0
11	Failure to Detect the Novel Retrovirus XMRV in Chronic Fatigue Syndrome 2010 ·PLoS ONE ·Otto Erlwein,Steve Kaye,Myra O. McClure,Jonathan Weber,Gillian Wills,David Collier,Simon Wessely,Anthony J. Cleare	153
12	The role of the gut mucosa in protection from HIV-1 in highly exposed persistently seronegative individuals (HEPS) 2009 ·HIV Medicine ·Julie Fox,Christian B. Willberg,Paul Ziprin,Robert Goldin,(unknown),Myra O. McClure,Paul Klenerman,Sarah Fidler	1
13	The role of human endogenous retroviruses in melanoma 2009 ·British Journal of Dermatology ·Sukhchain Singh,Steve Kaye,Martin Gore,Myra O. McClure,Clareann H. Bunker	32
14	Immunolipoplexes: An efficient, non-viral alternative for transfection of human dendritic cells with potential for clinical vaccination 2005 ·American Journal of Transplantation ·(unknown),Sven C. Beutelspacher,(unknown),Myra O. McClure,(unknown),Giovanna Lombardi,Andrew J.T. George	6
15	Specific Binding of Recombinant Foamy Virus Envelope Protein to Host Cells Correlates with Susceptibility to Infection 1999 ·Virology ·Ottmar Herchenröder,Dieter Moosmayer,Michael Bock,Thomas Pietschmann,Axel Rethwilm,Paul D. Bieniasz,Myra O. McClure,Roland Weís,Josef Schneider	15
16	Detection in chimpanzees of a novel flavivirus related to GB virus-C/hepatitis G virus. 1998 ·Journal of General Virology ·Nehkonti Adams,(unknown),Myra O. McClure,D. B. Smith,L. E. Prescott,Peter Simmonds,L M Jarvis	30
17	Association of Antibodies to Chlamydia trachomatis Heat-Shock Protein 60 kD with Chronic Nongonococcal Urethritis 1997 ·Clinical Infectious Diseases ·Paddy Horner,David Cain,Myra O. McClure,B J Thomas,C B Gilroy,(unknown),Jan Weber,D Taylor‐Robinson	32
18	Investigations into the Mechanism by Which Sulfated Polysaccharides Inhibit HIV Infection In Vitro 1992 ·AIDS Research and Human Retroviruses ·Myra O. McClure,John P. Moore,Dominique Blanc,Paul J. Scotting,Geoffrey M.W. Cook,Roger J. Keynes,Jonathan Weber,Donald S. Davies,Robin A. Weiss	156
19	The V3 Loops of the HIV-1 and HTV-2 Surface Glycoproteins Contain Proteolytic Cleavage Sites: A Possible Function in Viral Fusion? 1991 ·AIDS Research and Human Retroviruses ·Gary Clements,Molly Price-Jones,Paul E. Stephens,Chris W. Sutton,Thomas F. Schulz,Paul R. Clapham,Jane A. McKeating,Myra O. McClure,(unknown),Mark Marsh,John Kay,Robin A. Weiss,John P. Moore	219
20	Evidence for the dependence of arterial haemostasis on ADP 1988 ·Proceedings of the Royal Society of London. Series B, Biological sciences ·Myra O. McClure,(unknown),Noel J. Cusack,(unknown)	16

About Myra O. McClure

Myra O. McClure is a scholar working on Virology, Infectious Diseases and Microbiology, having authored 172 papers that have together received 6.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (68 papers), HIV/AIDS drug development and treatment (41 papers) and HIV/AIDS Research and Interventions (34 papers). The work is most often cited by research in Virology (2.5k citations), Infectious Diseases (2.1k citations) and Microbiology (502 citations). Myra O. McClure has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Robin A. Weiss, Jonathan Weber, Mark Marsh, Paul D. Bieniasz, Otto Erlwein, Massimo Pizzato, Yasuhiro Takeuchi, Bryan R. Cullen, David Muir and Steve Kaye. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact